Friday, February 24, 2012 3:26:33 PM
"PDUFA" – standing for the Prescription Drug User Fee Act!
As Mentioned in the previous post! Short periods before this date occurs will typically send a biomed or pharma stock higher. Until the FDA Deciosion date. And you know what happens if they send a complete reponse letter )CRL) or If they give an approval! This can cause the stock to plummet or skyrocket for small cap stocks!
As Mentioned in the previous post! Short periods before this date occurs will typically send a biomed or pharma stock higher. Until the FDA Deciosion date. And you know what happens if they send a complete reponse letter )CRL) or If they give an approval! This can cause the stock to plummet or skyrocket for small cap stocks!
Recent WINT News
- Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates • GlobeNewswire Inc. • 12/23/2025 02:00:00 PM
- Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space • GlobeNewswire Inc. • 12/03/2025 02:00:00 PM
- Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee • GlobeNewswire Inc. • 11/17/2025 02:00:00 PM
- Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate • GlobeNewswire Inc. • 11/14/2025 02:00:00 PM
- Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company • GlobeNewswire Inc. • 11/13/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 06:27:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 09:16:05 PM
- Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at the Special Stockholder Meeting • GlobeNewswire Inc. • 09/02/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2025 04:15:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 09:29:07 PM
- Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025 • GlobeNewswire Inc. • 08/11/2025 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2025 09:08:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:54:53 PM
- Windtree Announces Istaroxime Phase 2 Interim Analysis in SCAI Stage C Cardiogenic Shock Patients • GlobeNewswire Inc. • 08/05/2025 01:00:00 PM
- Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption • GlobeNewswire Inc. • 07/29/2025 01:01:29 PM
- Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy • GlobeNewswire Inc. • 07/24/2025 01:00:00 PM
- Kraken and Windtree Therapeutics Announce Strategic Partnership for BNB Custody, Trading, and OTC Services • GlobeNewswire Inc. • 07/22/2025 01:00:00 PM
- Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions • GlobeNewswire Inc. • 07/16/2025 01:22:53 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/14/2025 04:15:09 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/10/2025 01:23:56 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/07/2025 08:55:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 06:26:36 PM
- Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure • GlobeNewswire Inc. • 07/02/2025 01:00:00 PM
- Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis • GlobeNewswire Inc. • 06/30/2025 01:00:00 PM
- Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel • GlobeNewswire Inc. • 06/26/2025 08:05:00 PM
